XIFAXAN 200mg Rx
Generic Name and Formulations:
Rifaximin 200mg; tabs.
Valeant Pharmaceuticals, Inc
Indications for XIFAXAN 200mg:
Travelers' diarrhea due to noninvasive E. coli. Limitations of use: not for use if diarrhea is accompanied by fever or blood in stool, or if causative agent other than E. coli may be suspected (eg, C. jejuni, Shigella spp., Salmonella spp.).
200mg 3 times daily for 3 days.
Discontinue and reevaluate if diarrhea worsens or persists >24–48hrs. Not for treating systemic infections. Severe hepatic impairment (Child-Pugh C). Elderly. Pregnancy. Nursing mothers.
Potentiated by P-gp inhibitors (eg, cyclosporine); caution. Monitor INR and PT with warfarin; dose adjustment may be needed.
Flatulence, headache, abdominal pain, rectal tenesmus, defecation urgency, nausea.
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|